What Trump's reclassification of pot and CBD could mean for seniors, research and stocks

Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.

What Trump's reclassification of pot and CBD could mean for seniors, research and stocks
Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.